Page <#number#> of <#numberOfPages#>
Previous Page     Next Page        Smaller fonts | Larger fonts     com.yudu.plainText.returnToFlash

238

Part II Nutrition Assessment, Consequences, and Implications

histamine, and other pressor amines before they reach the systemic circulation. MAOIs block MAO activity, increasing the concentration of unoxidized pressor amines, such as tyramine, in the body. The inhibition of MAO by the MAOIs tranylcypromine (Parnate), phenelzine (Nardil), and isocarboxazid (Marplan) prevents the breakdown of tyramine, dopamine, or other pressor agents in foods such as aged cheeses or meats. The presence of these unoxidized pressor amines causes constriction of the blood vessels, which results in abnormal elevation of blood pres- sure, headaches, mood elevations, and possible death. When a drug with known MAOI activity is taken, foods high in pressor amines such as tyramine need to be avoided. Table 17.3 lists food supplements and drug interactions (see pages 248–249); Table 17.4 addresses common biochemical abnormalities associ- ated with medications prescribed for enterally fed patients (see page 250).

Alcohol

Many health care professionals overlook alcohol as a drug. The National Survey on Drug Use and Health conducted in 2010 found that nearly 40% of adults 65 and older drink alcohol (19). Unfortunately, many of these individuals may not consider the effect that alcohol can have on nutritional status and on medica- tions. Older adults have a lower tolerance for alcohol because they metabolize it more slowly as a result of having lower total body water; therefore, the blood alcohol becomes more concentrated in older adults. Nutritional assessment of the older adult suffering from alcoholism is a challenging task no matter the setting (eg, community, assisted living, nursing facility). Clinical signs and symptoms of alcohol-related malnu- trition are dependent on the stage of alcoholism, the level of socioeconomic integration, social and familial networks, alcohol- and nonalcohol-related conditions/ diseases (especially liver disease), and medication intake.

Alcohol interacts with most antidepressants, antibiot- ics, anticoagulants, and other drugs used for neurological benefits. It may also increase the GI irritation caused by medications such as aspirin or other nonsteroidal anti- inflammatory drugs (eg, ibuprofen). Chronic use of ethanol may increase the hepatotoxicity of medications such as acetaminophen or isoniazid.

Ethanol can also inhibit gluconeogenesis, thus prolonging a hypoglycemic episode induced by insulin or oral hypoglycemic agents (eg, glyburide [DiaBeta or Micronase]). In addition, the combination of disulfiram (Antabuse) and ethanol produces a potentially life-threatening reaction characterized by flushing,

rapid heartbeat, palpitations, and elevation of blood pressure.

Alcohol may also affect several nutrients.

Wernicke-Korsakoff syndrome, one consequence of long-term alcohol abuse, is associated with thiamin deficiency (20). Alcoholism is often connected to increased fracture risk, possibly due to the effects on vitamin D metabolism (21,22). The metabolism of all water-soluble vitamins may be affected by the con- sumption of alcohol. RDNs must pay closer attention to intakes of thiamin, riboflavin, niacin, vitamin B-6, folic acid, and vitamin C. In addition, increased iron absorption and decreased magnesium and zinc absorp- tion may occur (20).

Because alcohol is distributed throughout the body and is able to cross all membrane barriers, it is very likely to interact with a drug’s mechanism of action. For all medications, the RDN should review warnings to restrict or avoid alcohol and also be aware of the alcohol content within some drugs.

Caffeine Caffeine, depending on the amount consumed, can have differing effects on the central nervous system, cardio- vascular system, and metabolism. Symptoms can include a sense of alertness, decreased fatigue, and clear thinking when lower doses are consumed, but higher doses can cause tremors, restlessness, irritability, ner- vousness, and insomnia. In even higher doses, seizures and cardiovascular instability may occur. Caffeine should be avoided when taking certain antimicrobials and antibiotics as well as most antianxi- ety drugs. Caffeine-containing products should be avoided when taking drugs used to control gastro- esophageal reflux (heartburn), beta-blockers, or bron- chodilators. When limiting caffeine in the diet, it is important to consider OTC medications that may be high in caffeine such as appetite suppressants, caffeine pills, analgesics, and allergy/cold relief tablets. Box 17.5 outlines the drug-nutrient interaction issues asso- ciated with caffeine, as well as signs and symptoms of clinical excesses and withdrawal (23).

Grapefruit Juice

“Grapefruit juice and grapefruit product consumption have potential health benefits; however, intake is also associated with interactions with certain drugs, includ- ing calcium channel blockers, [antihyperlipidemics (HMG-CoA reductase inhibitors),] immunosuppres- sants, and antihistamines.” Citrus fruits such as grape- fruits, tangelos, limes, Seville oranges, and pomelos contain active ingredients that irreversibly block the drug metabolizing enzyme cytochrome P450 3A4. These foods inhibit metabolism of some drugs such as

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     com.yudu.plainText.returnToFlash
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216  |  Page 217  |  Page 218  |  Page 219  |  Page 220  |  Page 221  |  Page 222  |  Page 223  |  Page 224  |  Page 225  |  Page 226  |  Page 227  |  Page 228  |  Page 229  |  Page 230  |  Page 231  |  Page 232  |  Page 233  |  Page 234  |  Page 235  |  Page 236  |  Page 237  |  Page 238  |  Page 239  |  Page 240  |  Page 241  |  Page 242  |  Page 243  |  Page 244  |  Page 245  |  Page 246  |  Page 247  |  Page 248  |  Page 249  |  Page 250  |  Page 251  |  Page 252  |  Page 253  |  Page 254  |  Page 255  |  Page 256  |  Page 257  |  Page 258  |  Page 259  |  Page 260  |  Page 261  |  Page 262  |  Page 263  |  Page 264  |  Page 265  |  Page 266  |  Page 267  |  Page 268  |  Page 269  |  Page 270  |  Page 271  |  Page 272  |  Page 273  |  Page 274  |  Page 275  |  Page 276  |  Page 277  |  Page 278  |  Page 279  |  Page 280  |  Page 281  |  Page 282  |  Page 283  |  Page 284  |  Page 285  |  Page 286  |  Page 287  |  Page 288  |  Page 289  |  Page 290  |  Page 291  |  Page 292  |  Page 293  |  Page 294  |  Page 295  |  Page 296  |  Page 297  |  Page 298  |  Page 299  |  Page 300  |  Page 301  |  Page 302  |  Page 303  |  Page 304  |  Page 305  |  Page 306  |  Page 307  |  Page 308  |  Page 309  |  Page 310  |  Page 311  |  Page 312  |  Page 313  |  Page 314  |  Page 315  |  Page 316  |  Page 317  |  Page 318  |  Page 319  |  Page 320  |  Page 321  |  Page 322  |  Page 323  |  Page 324  |  Page 325  |  Page 326  |  Page 327  |  Page 328  |  Page 329  |  Page 330  |  Page 331  |  Page 332  |  Page 333  |  Page 334  |  Page 335  |  Page 336  |  Page 337  |  Page 338  |  Page 339  |  Page 340  |  Page 341  |  Page 342  |  Page 343  |  Page 344  |  Page 345  |  Page 346  |  Page 347  |  Page 348  |  Page 349  |  Page 350  |  Page 351  |  Page 352  |  Page 353  |  Page 354  |  Page 355  |  Page 356  |  Page 357  |  Page 358  |  Page 359  |  Page 360  |  Page 361  |  Page 362  |  Page 363  |  Page 364  |  Page 365  |  Page 366  |  Page 367  |  Page 368  |  Page 369  |  Page 370  |  Page 371  |  Page 372  |  Page 373  |  Page 374  |  Page 375  |  Page 376  |  Page 377  |  Page 378  |  Page 379  |  Page 380  |  Page 381  |  Page 382  |  Page 383  |  Page 384  |  Page 385  |  Page 386  |  Page 387  |  Page 388  |  Page 389  |  Page 390  |  Page 391  |  Page 392  |  Page 393  |  Page 394  |  Page 395  |  Page 396  |  Page 397  |  Page 398  |  Page 399  |  Page 400  |  Page 401  |  Page 402  |  Page 403  |  Page 404  |  Page 405  |  Page 406  |  Page 407  |  Page 408  |  Page 409  |  Page 410  |  Page 411  |  Page 412  |  Page 413  |  Page 414  |  Page 415